医学
心力衰竭
心肺适能
临床终点
急诊科
内科学
重症监护医学
物理疗法
急诊医学
心脏病学
干预(咨询)
退伍军人事务部
比例危险模型
探索性研究
临床试验
梅德林
心率
医疗急救
心室辅助装置
可穿戴计算机
物理医学与康复
随机对照试验
疾病严重程度
作者
Konstantinos Sideris,Carsten Matthias Schmalfuss,Neil Pendril Lewis,Karim Sallam,Biykem Bozkurt,Thomas C. Hanff,Michael T. Young,Richard Schofield,Christos P. Kyriakopoulos,Heather Hanson,Lina M. Brinker,Peter Wohlfahrt,Mandeep R. Mehra,Tempa Curry,Cheri Knecht,Stephanie Tuckett,Richard E. Nelson,Susan L Zickmund,Jorie M. Butler,Jay M. Edelberg
标识
DOI:10.1016/j.jchf.2026.103422
摘要
BACKGROUND: Artificial intelligence (AI)-enabled wearable monitoring can detect individualized physiological deviations preceding heart failure (HF) decompensation, but whether these signals can be translated into improved outcomes remains uncertain. OBJECTIVES: This study aims to evaluate the feasibility of integrating AI-generated notifications with a structured clinician response algorithm into postdischarge HF care and to explore their association with HF events following hospitalization. METHODS: LINK-HF2 (Detection of Physiological Anomaly Using Artificial Intelligence and Prevention of Heart Failure Hospitalization) was a prospective, randomized, open-label, blinded-endpoint study conducted at 5 Veterans Affairs medical centers. Adults hospitalized for acute HF were enrolled at discharge and assigned to AI-guided monitoring with clinician notification or to standard care. All participants wore a continuous multisensor patch for up to 90 days. A personalized similarity-based model detected deviations in cardiorespiratory and activity signals and generated notifications. Implementation outcomes included feasibility, acceptability, and usability. The main exploratory clinical endpoint was HF rehospitalization. Secondary exploratory clinical endpoints included the composite outcome of all-cause unplanned rehospitalizations, emergency department visits, and all-cause mortality. All clinical endpoints were compared through Cox proportional hazards models over the follow-up period. RESULTS: Among 171 analyzed participants, 80 (46.8%) were assigned to intervention and 91 (53.2%) to control. Median monitoring adherence was 72.4% of follow-up days; clinicians responded to communicated notifications within a median of 1 day (range: 1-5 days), and qualitative analysis demonstrated high patient acceptance and clinician engagement, whereas identifying workflow integration and response uncertainty as the primary barriers to implementation. In exploratory analyses, HF rehospitalization occurred in 13 (16.3%) patients in the intervention group and 17 (18.7%) in the control group (HR: 0.90, 95% CI: 0.43-1.84; P = 0.76). The composite clinical endpoint also did not differ between groups (HR 1.03; 95% CI: 0.63-1.70; P = 0.89). The intervention group had a lower rate of AI-detected physiological instability than controls (HR: 0.76; 95% CI: 0.60-0.97; P = 0.025). CONCLUSIONS: AI-enabled continuous physiological monitoring was feasible and reduced AI-detected physiological instability. Although this feasibility study did not demonstrate a reduction in exploratory clinical events, these findings highlight that accurate physiological risk detection alone may be insufficient to modify clinical risk without mechanistically aligned and trusted therapeutic responses. (Detection of Physiological Anomaly Using Artificial Intelligence and Prevention of Heart Failure Hospitalization [LINK-HF2]; NCT04502563).
科研通智能强力驱动
Strongly Powered by AbleSci AI